Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 274

1.

Myocardial infarction and other co-morbidities in patients with chronic obstructive pulmonary disease: a Danish nationwide study of 7.4 million individuals.

Sode BF, Dahl M, Nordestgaard BG.

Eur Heart J. 2011 Oct;32(19):2365-75. doi: 10.1093/eurheartj/ehr338. Epub 2011 Aug 29.

PMID:
21875856
2.

Chronic obstructive pulmonary disease and cancer risk: a Danish nationwide cohort study.

Kornum JB, Sværke C, Thomsen RW, Lange P, Sørensen HT.

Respir Med. 2012 Jun;106(6):845-52. doi: 10.1016/j.rmed.2011.12.009. Epub 2012 Jan 2.

3.

Skin cancer as a marker of sun exposure associates with myocardial infarction, hip fracture and death from any cause.

Brøndum-Jacobsen P, Nordestgaard BG, Nielsen SF, Benn M.

Int J Epidemiol. 2013 Oct;42(5):1486-96. doi: 10.1093/ije/dyt168. Epub 2013 Sep 13.

PMID:
24038635
4.

Inflammatory biomarkers and comorbidities in chronic obstructive pulmonary disease.

Thomsen M, Dahl M, Lange P, Vestbo J, Nordestgaard BG.

Am J Respir Crit Care Med. 2012 Nov 15;186(10):982-8. doi: 10.1164/rccm.201206-1113OC. Epub 2012 Sep 13.

PMID:
22983959
5.

Antidiabetes drugs correlate with decreased risk of lung cancer: a population-based observation in Taiwan.

Lai SW, Liao KF, Chen PC, Tsai PY, Hsieh DP, Chen CC.

Clin Lung Cancer. 2012 Mar;13(2):143-8. doi: 10.1016/j.cllc.2011.10.002. Epub 2011 Nov 29.

PMID:
22129971
6.

Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people.

Schramm TK, Gislason GH, Køber L, Rasmussen S, Rasmussen JN, Abildstrøm SZ, Hansen ML, Folke F, Buch P, Madsen M, Vaag A, Torp-Pedersen C.

Circulation. 2008 Apr 15;117(15):1945-54. doi: 10.1161/CIRCULATIONAHA.107.720847. Epub 2008 Mar 31.

PMID:
18378618
7.

Genetic and biochemical markers of obstructive lung disease in the general population.

Dahl M.

Clin Respir J. 2009 Apr;3(2):121-2. doi: 10.1111/j.1752-699X.2008.00110.x.

PMID:
20298391
8.

Falls and comorbidity: the pathway to fractures.

Jørgensen TS, Hansen AH, Sahlberg M, Gislason GH, Torp-Pedersen C, Andersson C, Holm E.

Scand J Public Health. 2014 May;42(3):287-94. doi: 10.1177/1403494813516831. Epub 2014 Jan 16.

PMID:
24434943
9.

Prognosis following first-time myocardial infarction in patients with psoriasis: a Danish nationwide cohort study.

Ahlehoff O, Gislason GH, Lindhardsen J, Olesen JB, Charlot M, Skov L, Torp-Pedersen C, Hansen PR.

J Intern Med. 2011 Sep;270(3):237-44. doi: 10.1111/j.1365-2796.2011.02368.x. Epub 2011 Mar 24.

10.

Antidepressants and risk of first-time hospitalization for myocardial infarction: a population-based case-control study.

Monster TB, Johnsen SP, Olsen ML, McLaughlin JK, Sørensen HT.

Am J Med. 2004 Nov 15;117(10):732-7.

PMID:
15541322
11.

Impact of chronic obstructive pulmonary disease on acute-phase outcome of myocardial infarction.

Wakabayashi K, Gonzalez MA, Delhaye C, Ben-Dor I, Maluenda G, Collins SD, Syed AI, Gaglia MA Jr, Torguson R, Xue Z, Suddath WO, Satler LF, Kent KM, Lindsay J, Pichard AD, Waksman R.

Am J Cardiol. 2010 Aug 1;106(3):305-9. doi: 10.1016/j.amjcard.2010.03.026. Epub 2010 Jun 18.

PMID:
20643237
12.

Estrogen receptor alpha polymorphism and risk of cardiovascular disease, cancer, and hip fracture: cross-sectional, cohort, and case-control studies and a meta-analysis.

Kjaergaard AD, Ellervik C, Tybjaerg-Hansen A, Axelsson CK, Grønholdt ML, Grande P, Jensen GB, Nordestgaard BG.

Circulation. 2007 Feb 20;115(7):861-71.

PMID:
17309937
13.
14.

Diabetes and stress hyperglycemia associated with myocardial infarctions at an urban municipal hospital: prevalence and effect on mortality.

Nordin C, Amiruddin R, Rucker L, Choi J, Kohli A, Marantz PR.

Cardiol Rev. 2005 Sep-Oct;13(5):223-30.

PMID:
16106183
15.

Patients diagnosed with diabetes are at increased risk for asthma, chronic obstructive pulmonary disease, pulmonary fibrosis, and pneumonia but not lung cancer.

Ehrlich SF, Quesenberry CP Jr, Van Den Eeden SK, Shan J, Ferrara A.

Diabetes Care. 2010 Jan;33(1):55-60. doi: 10.2337/dc09-0880. Epub 2009 Oct 6.

16.

Integrin beta3 Leu33Pro polymorphism and risk of hip fracture: 25 years follow-up of 9233 adults from the general population.

Tofteng CL, Bach-Mortensen P, Bojesen SE, Tybjaerg-Hansen A, Hyldstrup L, Nordestgaard BG.

Pharmacogenet Genomics. 2007 Jan;17(1):85-91.

PMID:
17264806
17.

Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial.

Aguilar D, Solomon SD, Køber L, Rouleau JL, Skali H, McMurray JJ, Francis GS, Henis M, O'Connor CM, Diaz R, Belenkov YN, Varshavsky S, Leimberger JD, Velazquez EJ, Califf RM, Pfeffer MA.

Circulation. 2004 Sep 21;110(12):1572-8. Epub 2004 Sep 13.

PMID:
15364810
18.

Risk of hospitalization for myocardial infarction among users of rofecoxib, celecoxib, and other NSAIDs: a population-based case-control study.

Johnsen SP, Larsson H, Tarone RE, McLaughlin JK, Nørgård B, Friis S, Sørensen HT.

Arch Intern Med. 2005 May 9;165(9):978-84.

PMID:
15883235
19.

Impact of chronic obstructive pulmonary disease on post-myocardial infarction outcomes.

Salisbury AC, Reid KJ, Spertus JA.

Am J Cardiol. 2007 Mar 1;99(5):636-41. Epub 2007 Jan 9.

PMID:
17317363
20.

Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction: results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) Registry.

Malmberg K, Yusuf S, Gerstein HC, Brown J, Zhao F, Hunt D, Piegas L, Calvin J, Keltai M, Budaj A.

Circulation. 2000 Aug 29;102(9):1014-9.

PMID:
10961966

Supplemental Content

Support Center